PCSK9 inhibitors: a race to become the next new cholesterol blockbuster Feb. 27, 2014 By Ulrike Jahnke No Comments LONDON – PCSK9 inhibitors have been hailed the most important new heart drugs in years, with resulting multibillion-dollar sales potential.Read More
